1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 31-40 of 73 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trialVermorken, J.; Stohlmacher-Williams, J.; Davidenko, I.; Licitra, L.; Winquist, E.; Villanueva, C.; Foa, P.; Rottey, S.; SkladowskI, K.; Tahara, M.; Pai, V.; Faivre, S.; Blajman, C.; Forastiere, A.; Stein, B.; Oliner, K.; Pan, Z.; Bach, B.
2022Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry.Figtree, G.A.; Vernon, S.T.; Hadziosmanovic, N.; Sundström, J.; Alfredsson, J.; Nicholls, S.J.; Chow, C.K.; Psaltis, P.; Røsjø, H.; Leósdóttir, M.; Hagström, E.
2021Rates, predictors, and impact of smoking cessation after stroke or transient ischemic attack: a systematic review and meta-analysisNoubiap, J.J.; Fitzgerald, J.L.; Gallagher, C.; Thomas, G.; Middeldorp, M.E.; Sanders, P.
2015Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three yearsWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2004Effect of body mass index on defibrillation thresholds for internal cardioversion in patients with atrial fibrillationKistler, P.; Sanders, P.; Morton, J.; Vohra, J.; Kalman, J.; Sparks, P.
2004Bisphosphonate infusions: patient preference, safety and clinic useChern, B.; Joseph, D.; Joshua, D.; Pittman, K.; Richardson, G.; Schou, M.; Lowe, S.; Copeman, M.; De Abreu Lourenco, R.; Lynch, K.
2008Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: A randomized, double-blind, double-dummy, two-way, crossover studyChristrup, L.; Foster, D.; Popper, L.; Troen, T.; Upton, R.
2001Donor and recipient risk factors and choice of immunosuppression determine long-term outcome in renal transplantationMathew, T.; McDonald, S.; Russ, G.
2000Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosaKlinkenberg-Knol, E.; Nelis, F.; Dent, J.; Snel, P.; Mitchell, B.; Prichard, P.; Lloyd, D.; Havu, N.; Frame, M.; Roman, J.; Walan, A.
2006Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexateMurphy, N.; Diviney, M.; Szer, J.; Bardy, P.; Grigg, A.; Hoyt, R.; King, B.; MacGregor, L.; Holdsworth, R.; McCluskey, J.; Tait, B.

Discover